These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16917838)

  • 81. Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice.
    Leder C; Schwab N; Ip CW; Kroner A; Nave KA; Dornmair K; Martini R; Wiendl H
    Mol Cell Neurosci; 2007 Nov; 36(3):416-24. PubMed ID: 17889554
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
    Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M
    Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Electrophysiology in demyelinating polyneuropathies.
    Franssen H
    Expert Rev Neurother; 2008 Mar; 8(3):417-31. PubMed ID: 18345972
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Action potential refractory period in axonal demyelination: a computer simulation.
    Quandt FN; Davis FA
    Biol Cybern; 1992; 67(6):545-52. PubMed ID: 1335294
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Decompaction of CNS myelin leads to a reduction of the conduction velocity of action potentials in optic nerve.
    Gutiérrez R; Boison D; Heinemann U; Stoffel W
    Neurosci Lett; 1995 Aug; 195(2):93-6. PubMed ID: 7478276
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A recombinant human IgM promotes myelin repair after a single, very low dose.
    Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M
    J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Axonal multifocal neuropathy without conduction block or other features of demyelination.
    Menkes DL
    Neurology; 2002 Nov; 59(10):1666; author reply 1667. PubMed ID: 12451229
    [No Abstract]   [Full Text] [Related]  

  • 88. Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice.
    Johnson RS; Roder JC; Riordan JR
    J Neurochem; 1995 Mar; 64(3):967-76. PubMed ID: 7532214
    [TBL] [Abstract][Full Text] [Related]  

  • 89. CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology.
    Smorodchenko A; Wuerfel J; Pohl EE; Vogt J; Tysiak E; Glumm R; Hendrix S; Nitsch R; Zipp F; Infante-Duarte C
    Eur J Neurosci; 2007 Sep; 26(6):1387-98. PubMed ID: 17880383
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The expansion of 300 CTG repeats in myotonic dystrophy transgenic mice does not induce sensory or motor neuropathy.
    Gantelet E; Kraftsik R; Delaloye S; Gourdon G; Kuntzer T; Barakat-Walter I
    Acta Neuropathol; 2007 Aug; 114(2):175-85. PubMed ID: 17318633
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effects of demyelination on conduction in the central nervous system.
    McDonald WI; Sears TA
    Trans Am Neurol Assoc; 1969; 94():168-73. PubMed ID: 5374431
    [No Abstract]   [Full Text] [Related]  

  • 92. A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy.
    Pineda AA; Ogata K; Osoegawa M; Murai H; Shigeto H; Yoshiura T; Tobimatsu S; Kira J
    J Neurol Sci; 2007 Apr; 255(1-2):1-6. PubMed ID: 17306302
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Simulating focal demyelinating neuropathies: membrane property abnormalities.
    Stephanova DI; Alexandrov AS; Kossev A; Christova L
    Biol Cybern; 2007 Feb; 96(2):195-208. PubMed ID: 17072638
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Myelin structure in proteolipid protein (PLP)-null mouse spinal cord.
    Rosenbluth J; Stoffel W; Schiff R
    J Comp Neurol; 1996 Jul; 371(2):336-44. PubMed ID: 8835737
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Release of surfactant and a myelin proteolipid apoprotein in spinal tissue by decompression.
    Hills BA
    Undersea Hyperb Med; 1994 Jun; 21(2):95-102. PubMed ID: 7520309
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependent.
    Mastronardi FG; Ackerley CA; Roots BI; Moscarello MA
    J Neurosci Res; 1996 May; 44(4):301-7. PubMed ID: 8739149
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Conduction in segmentally demyelinated mammalian central axons.
    Felts PA; Baker TA; Smith KJ
    J Neurosci; 1997 Oct; 17(19):7267-77. PubMed ID: 9295373
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Where, when and how much: regulation of myelin proteolipid protein gene expression.
    Wight PA; Dobretsova A
    Cell Mol Life Sci; 2004 Apr; 61(7-8):810-21. PubMed ID: 15095005
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effect of a demyelinating lesion on conduction in the central nervous system studied in single nerve fibres.
    McDonald WI; Sears TA
    J Physiol; 1970 Apr; 207(2):53P-54P. PubMed ID: 5511135
    [No Abstract]   [Full Text] [Related]  

  • 100. [Biochemical and pharmacological approach to the functional disorders observed in demyelination mutants (GABAergic and noradrenergic systems)].
    Baumann N; Maurin Y; Puech A; Chauvel P; Simon P
    C R Seances Soc Biol Fil; 1980; 174(4):437-45. PubMed ID: 6254620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.